Clin Mol Hepatol.
2023 Apr;29(2):404-407. 10.3350/cmh.2023.0069.
Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore
- 2Yong Loo Lin School of Medicine, National University of Singapore, Singapore
- KMID: 2541429
- DOI: http://doi.org/10.3350/cmh.2023.0069
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
- A Case of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
- Risk of Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease
- Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
- Hepatocellular Carcinoma Arising from Non-Cirrhotic Non-Alcoholic Steatohepatitis
